CYTOMEGALOVIRUS PREVALENCE IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS FROM A MEXICAN ONCOLOGIC REFERENCE CENTER

被引：0
|
作者：
Valero-Saldana, L. M. [1 ]
Vallejo-Cervantes, J. L. [2 ]
Aguado-Vazquez, T. [3 ]
Rivera-Fong, L. [1 ]
Cervantes-Perez, L. [1 ]
Moreira-Perez, C. [1 ]
Garzon-Velazquez, K. [1 ]
Lugo, G. [3 ]
Acosta-Maldonado, B. [1 ]
机构：
[1] Inst Nacl Cancerol, EM, Mexico City, DF, Mexico
[2] Merck Sharp & Dohme Ltd, Mexico City, DF, Mexico
[3] Merck Sharp & Dohme Ltd, Oncol, Mexico City, DF, Mexico
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EPH203
引用
收藏
页码：S189 / S189
页数：1
相关论文
共 50 条
  • [21] Letermovir prophylaxis for cytomegalovirus reactivation in allogeneic hematopoietic cell transplant recipients: Single center Canadian data
    Pang, Ian
    Chen, Peggy
    Trinh, Gertrude V.
    Remberger, Mats
    Novitzky-Basso, Igor
    Gerbitz, Armin
    Kim, Dennis D.
    Kumar, Rajat
    Lam, Wilson
    Law, Arjun D.
    Lipton, Jeffrey H.
    Viswabandya, Auro
    Pasic, Ivan
    Mattsson, Jonas
    Michelis, Fotios V.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (02) : 301 - 309
  • [22] Primary care for allogeneic hematopoietic stem cell transplant recipients
    Fulcher, Jill
    Hertz, Sherrie
    Bredeson, Christopher
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (06) : E225 - E226
  • [23] Oral valganciclovir as preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients
    Katsuto Takenaka
    Tetsuya Eto
    Koji Nagafuji
    Kenjiro Kamezaki
    Yayoi Matsuo
    Goichi Yoshimoto
    Naoki Harada
    Maki Yoshida
    Hideho Henzan
    Ken Takase
    Toshihiro Miyamoto
    Koichi Akashi
    Mine Harada
    Takanori Teshima
    International Journal of Hematology, 2009, 89 : 231 - 237
  • [24] Iron Overload in Allogeneic Hematopoietic Stem Cell Transplant Recipients
    Ali, Sharif
    Pimentel, Jason D.
    Munoz, Javier
    Shah, Veena
    McKinnon, Rick
    Divine, George
    Janakiraman, Nalini
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2012, 136 (05) : 532 - 538
  • [25] Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment
    Solano, Carlos
    Vazquez, Lourdes
    Gimenez, Estela
    de la Camara, Rafael
    Albert, Eliseo
    Rovira, Montserrat
    Espigado, Ildefonso
    Calvo, Carmen Martin
    Lopez-Jimenez, Javier
    Suarez-Lledo, Maria
    Chinea, Anabella
    Esquirol, Albert
    Perez, Ariadna
    Bermudez, Aranzazu
    Saldana, Raquel
    Heras, Inmaculada
    Gonzalez-Huerta, Ana Julia
    Torrado, Tamara
    Batlle, Montserrat
    Jimenez, Santiago
    Vallejo, Carlos
    Barba, Pere
    Cuesta, Maria angeles
    Pinana, Jose Luis
    Navarro, David
    BONE MARROW TRANSPLANTATION, 2021, 56 (06) : 1281 - 1290
  • [26] Oral valganciclovir as preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients
    Takenaka, Katsuto
    Eto, Tetsuya
    Nagafuji, Koji
    Kamezaki, Kenjiro
    Matsuo, Yayoi
    Yoshimoto, Goichi
    Harada, Naoki
    Yoshida, Maki
    Henzan, Hideho
    Takase, Ken
    Miyamoto, Toshihiro
    Akashi, Koichi
    Harada, Mine
    Teshima, Takanori
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 89 (02) : 231 - 237
  • [27] Detection of cytomegalovirus specific cytotoxic T lymphocyte in allogeneic hematopoietic stem cell transplant recipients.
    Sun, J
    Huang, T
    Yi, ZS
    Liu, QF
    Xu, D
    Ye, CX
    Meng, FY
    BLOOD, 2005, 106 (11) : 421B - 421B
  • [28] Effectiveness of letermovir for cytomegalovirus prophylaxis in allogeneic hematopoietic stem cell transplant recipients: A global systematic review
    Sepassi, Aryana
    Saunders, Ila M.
    Bounthavong, Mark
    Taplitz, Randy A.
    Logan, Cathy
    Watanabe, Jonathan H.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2023, 63 (04) : 1138 - 1149
  • [29] Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment
    Carlos Solano
    Lourdes Vázquez
    Estela Giménez
    Rafael de la Cámara
    Eliseo Albert
    Montserrat Rovira
    Ildefonso Espigado
    Carmen Martín Calvo
    Javier López-Jiménez
    María Suárez-Lledó
    Anabella Chinea
    Albert Esquirol
    Ariadna Pérez
    Aránzazu Bermúdez
    Raquel Saldaña
    Inmaculada Heras
    Ana Julia González-Huerta
    Tamara Torrado
    Montserrat Batlle
    Santiago Jiménez
    Carlos Vallejo
    Pere Barba
    María Ángeles Cuesta
    José Luis Piñana
    David Navarro
    Bone Marrow Transplantation, 2021, 56 : 1281 - 1290
  • [30] Overview of cytomegalovirus viremia in allogeneic hematopoietic stem cell transplant recipients: Experience of a population with high seroprevalence
    Bourlon de los Rios, C.
    Vargas Serafin, C. O.
    Toledo Riquelme, A. K.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 294 - 295
12345